chronic obstructive pulmonary disease (COPD)

Showing 1 posts of 1 posts found.

EpiEndo publishes new data supporting glasmacinal’s potential in COPD

June 13, 2025
Medical Communications, Research and Development Chronic Diseases, EpiEndo Pharmaceuticals, Fraunhofer Institute for Toxicology and Experimental Medicine, antimicrobial resistance, chronic obstructive pulmonary disease (COPD), lung disease

EpiEndo Pharmaceuticals has announced the publication of three peer-reviewed articles in Pulmonary Pharmacology and Therapeutics, highlighting the therapeutic potential of …

The Gateway to Local Adoption Series

Latest content